|Articles|June 27, 2022
Tips for Tailoring eConsent for Optimal Patient Centricity
Author(s)Medable
Over 70% of potential research participants live >2 hours away from a research site, & patient drop-out rates can reach 30% depending on the therapeutic area. The Solution: Medable eConsent Why? 1. Medable eConsent enables the enrollment of underrepresented, diverse populations through remote consenting. 2. Medable eConsent has proven to reduce screening timelines by 50%, & increase patient engagement by 15%+.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
European Parliament Revamps Pharmaceutical Policy Framework
2
Regulatory Expectations for Evaluating GMP Facilities and Equipment
3
Tjoapack’s Advanced Packaging Expansion Aims to Meet Rising Demand
4
Optimizing Pharmaceutical Manufacturing Efficiency
5
